Home › Malattie cardiovascolari › Indiana › Indianapolis
Studi clinici su Malattie cardiovascolari a Indianapolis, IN
16 studi su Malattie cardiovascolari cercano partecipanti presso sedi a Indianapolis e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
In reclutamentoFase 2
- Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
In reclutamentoFase 3
- American Health Network - Avon, Avon · a 13 mi di distanza
Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)
In reclutamento
- Ascension Saint Vincent Hospital - Indianapolis, Indianapolis
Product Surveillance Registry
In reclutamentoStudio osservazionale
- Indianapolis, Indianapolis
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
In reclutamentoFase 3
- Clinical Trial Site, Avon · a 13 mi di distanza
- Clinical Trial Site, Whiteland · a 16 mi di distanza
Zenith® Fenestrated+ Clinical Study
In reclutamento
- Methodist Hospital of Indiana, Indianapolis
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
In reclutamento
- Ascension St. Vincent Hospital - Indianapolis, Indianapolis
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
In reclutamentoFase 3
- Krannert Institute of Cardiology, Indianapolis
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
In reclutamentoFase 4Volontari sani benvenuti
- Indianapolis VA Medical Center, Indianapolis
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
In reclutamentoFase 3
- Research Site, Indianapolis
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
In reclutamentoFase 3
- Franciscan Health Indianapolis, Indianapolis
- Ascension Saint Vincent Heart Center, Indianapolis
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
In reclutamento
- Ascension St. Vincent's, Indianapolis
Pediatric Cardiomyopathy Mutation Analysis
In reclutamentoStudio osservazionale
- IU School of Medicine, Indianapolis
Molecular Genetics of Heterotaxy and Related Congenital Heart Defects
In reclutamentoStudio osservazionale
- Indiana University School of Medicine, Indianapolis
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
In reclutamento
- St. Vincent Hospital, Indianapolis
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
In reclutamento
- Community Health Network, Indianapolis
Studi su Malattie cardiovascolari in altre città
- Boston, MA37 studi
- New York City, NY33 studi
- Washington, DC29 studi
- Houston, TX24 studi
- Dallas, TX23 studi
- Atlanta, GA22 studi
- Cleveland, OH22 studi
- Chicago, IL21 studi
- Philadelphia, PA21 studi
- Pittsburgh, PA20 studi
- St. Louis, MO20 studi
- San Francisco, CA18 studi
Altri studi a Indianapolis
- Cancro del polmone non a piccole cellule32 studi
- Cancro (tutti i tipi)24 studi
- Insufficienza cardiaca23 studi
- Cancro al seno20 studi
- Obesità20 studi
- Cancro metastatico19 studi
- Cancro colorettale18 studi
- Cancro ovarico17 studi
- Cancro ai polmoni16 studi
- Diabete di tipo 114 studi
- Cancro dell'endometrio14 studi
- Morbo di Alzheimer14 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.